Twitchy Times At GSK As Activist Investor Takes Big Stake
Elliott Management Has History In Demanding Changes
GlaxoSmithKline's market value has slipped in the past three years and the number of failures in the clinic have grown. The major's leadership will be casting nervous glances towards a major shareholder that has a reputation for aggressive restructuring calls.
